Clinical Trials Day is a well-deserved ‘time out’ to recognize the people who conduct clinical trials and to say “thanks” for what they do every day to improve public health.
Our non-profit parent organization is getting some much deserved publicity.
On the Town: People need to know about Lynn Institute https://t.co/mV0dHz7xYM
A Sickle Cell disease study is now enrolling participants at our Tulsa location! Receive compensation for your time and travel and expert study-related medical care at no cost. Call (918) 619-6410 or visit https://t.co/gsZyfKN6sn for more information!
The Lynn Institute of Oklahoma City is now enrolling participants in a Cytomegalovirus (CMV) vaccine study! Healthy women ages 16-35. Receive compensation for time and travel and expert, study-related medical care at no cost. For more information, call 405-447-8839.
A Sickle Cell disease study is now enrolling participants at our Tulsa location! Receive compensation for your time and travel and expert study-related medical care at no cost. Call (918) 619-6410 or visit https://t.co/gsZyfKN6sn for more information!
The Lynn Institute of OKC is now enrolling participants age 65 years or older in the CYPRESS study assessing the study vaccine to prevent RSV. Want more information? Give us a call at 405-447-8839!
The Lynn Institute of Oklahoma City is now enrolling participants ages 18-45 for a smallpox vaccine study! Participants will receive compensation for their time & travel & study-related medical care at no cost. Interested? Visit https://t.co/gsZyfKN6sn or call (405) 447-8839.
Routine smallpox vaccination of the public stopped in 1972. That means there are approximately 190 million Americans that have not been vaccinated against the virus.
Learn more about Smallpox and outbreak potential at https://t.co/GqQkNsUwlW.
We're now enrolling for an acne study at the Lynn Institute of OKC! Participants receive compensation for time and travel and all study-related medical care at NO COST. Want to learn more? Call (405) 447-8839 or visit https://t.co/tUhufrZz3a today!